Article
The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study.
Translational psychiatry - 4 Sept 2021
Liu Jiahong, Wang Pingping, Sun Leilei, Guan Xiaoni, Xiu Meihong, Zhang Xiangyang
Abstract excerpt
A growing number of studies have shown that brain-derived neurotrophic factor (BDNF) is associated with weight gain during antipsychotic treatment in schizophrenia patients. However, there is still a lack of research results in the initial stage of antipsychotic treatment. This study aimed to evaluate the relationship between weight gain caused by risperidone monotherapy for 12 weeks and BDNF level in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.